Sunday, January 17, 2016

A final rant about pharmaceutical companies

Sorry—I can’t stop ranting about drug companies. (Look at the Topics menu for more rants on the subject.) Lately, there’s been a brouhaha about the increase in the cost of a Daraprim, a 62-year-old infectious disease drug that was recently acquired by Turing Pharmaceuticals. Turing immediately raised the price from $13.50 a tablet to $750 a tablet. (The CEO, Martin Shkreli, was arrested December 19th last year on securities fraud charges—essentially for a Ponzi-like scheme.)

Pharmaceutical companies want you to think their prices are high because they spend so much on research and development. That’s hogwash. Their prices are high because they’re trying to make the biggest profits they can get away with. Like Turing, their strategy is to buy companies and/or drugs, after which they jack up the drug prices. Here's another example: Valeant Pharmaceuticals International spends just 3 percent of sales on R and D, which they consider to be “inefficient” and “risky”. Valeant bought the rights to Isuprel, a heart medication, and immediately raised the price of 25 pills from $4,489 to $36,811. Similarly, 100 capsules of Cuprimine, a drug for Wilson’s disease, rose from $888 to $26,189. (In some foreign countries that same drug sells for $1.00 a capsule.) In all, Valeant has raised the prices of its brand-name drugs an average of 66 percent.

Executive pay, by the way, is tied to shareholder returns. Last year, Valeant spent $123 million on the five highest-paid executives. Its president, J. Michael Pearson has become a billionaire. Although Pearson operates out of an office in New Jersey, the company has relocated to Canada for its tax advantages. 

While their profits have generated wealth for shareholders, it’s not been so great for the employees who worked for the companies acquired by Valeant. Many, if not most, have lost their jobs. For example, after acquiring Bausch & Lomb, Valeant fired 3,000 of the original 4,103 workers. 

Valeant and Turing may be extreme examples, but I think many if not most of these companies are immoral, if not downright evil. For my part, I just say no to drugs. I’m glad I can do that.

Next week: Inflammation I: My accident

For an introduction to this blog, see I Just Say No; for a list of blog topics, click the Topics tab.


Sunday, January 10, 2016

Fear not: a summing up of 2015

In his book, Less Medicine, More Health, Dr. Gilbert Welch concludes, “If the American public knew the full story about the benefits, harms, and uncertainties of medical care, many would choose to have less…meaning the interventions of testing, medication, procedures, surgeries, and devices.” This is the position I have taken, as discussed in my years’ worth of posts in 2015. For me, this means—

  • Not going to the doctor unless I’m sick; in other words, no annual checkups.
  • Not worrying about cholesterol, germs, saturated fat, or most anything else.
  • Not getting mammograms or other screening tests.
  • Not using prescription medicines (I admit to taking Advil pretty regularly).
  • Not getting flu shots.
  • Etc.

 My rationale is based on a number of things, most of which I’ve gleaned from my research:
  • I don’t get sick (admittedly, this is dumb luck).
  • Forty percent of doctors’ treatments have no value.
  • Ninety percent of scientific journal articles are flawed.
  • Pharmaceutical and device companies drive much of medical practices.
  • Accepted medical practices are often discovered—too late—to have been wrong-headed and harmful.

I’m willing to go to the doctor if the situation calls for it. (My last visit was about four years ago, when I had wax removed from my ear and my do-it-yourself efforts using Debrox were unsuccessful). I refuse to worry about some hidden malady that might be lurking in my body just waiting to be discovered by a test. Where my health is concerned, I don’t believe in “better safe than sorry.” I believe in “if it ain’t broke, don’t fix it.”

Next week: Another rant about pharmaceutical companies

For an introduction to this blog, see I Just Say No; for a list of blog topics, click the Topics tab.

Sunday, January 3, 2016

Cartoons for the holidays II


Next week: Fear not: a summing up of 2015

For an introduction to this blog, see I Just Say No; for a list of blog topics, click the Topics tab.



Sunday, December 27, 2015

Cartoons for the holidays I

Next week: Three more cartoons

For an introduction to this blog, see I Just Say No; for a list of blog topics, click the Topics tab.